<div id="readability-page-1"><div>DSS, INC., a diversified holding company with interests in various sectors including product packaging, biotechnology, commercial lending, securities, and direct marketing, has released its Form 10-Q report for the third quarter of 2025. The report highlights significant improvements in financial performance and provides insights into the company's operational achievements and future outlook. Financial Highlights Total Revenue: $6.39 million for the three months ended September 30, 2025, reflecting an increase from $5.60 million in the same period of 2024.Total Revenue: $16.63 million for the nine months ended September 30, 2025, compared to $13.68 million in the same period of 2024.Operating Loss: $(3.23) million for the three months ended September 30, 2025, an improvement from $(4.67) million in the same period of 2024.Operating Loss: $(10.38) million for the nine months ended September 30, 2025, compared to $(14.29) million in the same period of 2024.Net Loss: $(2.23) million for the three months ended September 30, 2025, compared to $(5.70) million in the same period of 2024.Net Loss: $(10.09) million for the nine months ended September 30, 2025, compared to $(15.76) million in the same period of 2024.Net Loss Attributable to DSS Common Stockholders: $(2.30) million for the three months ended September 30, 2025, compared to $(5.28) million in the same period of 2024.Net Loss Attributable to DSS Common Stockholders: $(9.18) million for the nine months ended September 30, 2025, compared to $(14.03) million in the same period of 2024.Loss Per Common Share Attributable to Common Stockholders - Basic and Diluted: $(0.25) for the three months ended September 30, 2025, compared to $(0.75) in the same period of 2024.Loss Per Common Share Attributable to Common Stockholders - Basic and Diluted: $(1.03) for the nine months ended September 30, 2025, compared to $(1.99) in the same period of 2024. Business Highlights Product Packaging Segment: The Product Packaging line, led by Premier Packaging Corporation, operates in the paperboard and fiber-based folding carton markets, providing sophisticated custom folding cartons and document security printing solutions. This segment primarily serves the US market from its facility in Rochester, NY.Biotechnology Segment: The Biotechnology business line focuses on investing in or acquiring companies in the BioHealth and BioMedical fields, targeting drug discovery and treatment of neurological, oncological, and immune-related diseases. It is also developing open-air defense initiatives to curb airborne infectious diseases.Commercial Lending Segment: Driven by American Pacific Financial, this segment is organized to acquire equity positions in undervalued commercial banks and nonbanking financial companies across the US and Asia. It offers services like loan syndication, mortgage banking, and advisory capital raising.Securities and Investment Management Segment: This segment develops and acquires assets in securities trading and management, including broker-dealers and mutual funds. It also includes a real estate investment trust (REIT) focused on acquiring and leasing medical real estate.Direct Marketing Segment: Led by Decentralized Sharing Systems, this segment provides services for peer-to-peer decentralized sharing marketplaces, offering nutritional and personal care products across North America, Asia Pacific, and Eastern Europe.Geographical Performance: The company operates globally with significant activities in the US, South East Asia, Taiwan, Japan, and South Korea, reflecting its diverse market presence.Future Outlook: The company plans to continue evaluating its merger and share exchange agreement with Dr. Ashleys Limited, pending regulatory approval. Management is focused on reducing expenses and cash burn across all business lines to ensure sustainability.SEC Filing: DSS, INC. [ DSS ] - 10-Q - Nov. 14, 2025</div></div>

DSS, INC. released its Q3 2025 10-Q report, showing improved financial performance. Revenue rose to $6.39M for Q3 2025, up from $5.60M in Q3 2024. Operating loss improved to $(3.23) M from $(4.67) M, and net loss reduced to $(2.23) M from $(5.70) M. The company operates in diverse sectors and plans to reduce expenses and cash burn for sustainability.

DSS, INC. SEC 10-Q Report